Atlanthera’s concept is based on bisphosphonate (HBP) natural affinity to bone tissue.
HBP is routinely used in the standard of care for bone cancer and bone diseases and has the following characteristics:
- Suppress bone breakdown
- Reduce pain
- Reduce hypercalcemia
- Extensively used as osteoporosis treatment
Atlanthera’s concept couples HBP to an active compound to treat bone diseases, bone cancer, bone inflammation… The use of a specifically designed linker enables the specific release on bone surface:
